Metoclopramide and Chest wall abscess - a phase IV clinical study of FDA data

Summary:

Chest wall abscess is reported as a side effect among people who take Metoclopramide (metoclopramide hydrochloride), especially for people who are female, 40-49 old, also take Dilaudid, and have Osteoarthritis.

The phase IV clinical study analyzes which people have Chest wall abscess when taking Metoclopramide. It is created by eHealthMe based on reports of 80,804 people who have side effects when taking Metoclopramide from the FDA, and is updated regularly.

What is Metoclopramide?

Metoclopramide has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 81,263 Metoclopramide users. Check the latest studies of Metoclopramide.

What is Chest wall abscess?

Chest wall abscess is found to be associated with 52 drugs and 117 conditions by eHealthMe. Check the latest studies of Chest wall abscess.

On Jul, 28, 2026

80,804 people reported to have side effects when taking Metoclopramide.
Among them, 12 people (0.01%) have Chest wall abscess.

Could Metoclopramide cause Chest wall abscess?

Among these 12 people:

What is the gender of people who have Chest wall abscess when taking Metoclopramide? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Chest wall abscess when taking Metoclopramide? *

What are other drugs people take besides Metoclopramide? *

What are other side effects people have besides Chest wall abscess? *

Hyperglycemia (high blood sugar): 7 people, 58.33%
Intervertebral Disc Degeneration (spinal disc degeneration): 7 people, 58.33%
Oedema (fluid collection in tissue): 7 people, 58.33%
Neoplasm Progression (growth of tumour): 7 people, 58.33%
Neoplasm Malignant (cancer tumour): 7 people, 58.33%
Necrotising Fasciitis (an uncommon life-threatening soft-tissue infection): 7 people, 58.33%
Neck Pain: 7 people, 58.33%
Metastases To Bone (cancer spreads to bone): 7 people, 58.33%
Colon Cancer: 7 people, 58.33%
Kidney Stones: 7 people, 58.33%

What are the existing conditions these people have? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 7 people, 58.33%
Multiple Myeloma (cancer of the plasma cells): 6 people, 50.00%
White Blood Cell Count Increased: 5 people, 41.67%
Vulvovaginal Candidiasis (vulvovaginal infection by fungi): 5 people, 41.67%
Skin Reaction: 5 people, 41.67%
Rashes (redness): 5 people, 41.67%
Oropharyngeal Pain: 5 people, 41.67%
Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 5 people, 41.67%
Joint Pain: 5 people, 41.67%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 5 people, 41.67%

* Approximation only. Some reports may have incomplete information.

Do you take Metoclopramide and have Chest wall abscess?

- Check whether Chest wall abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoclopramide:

Metoclopramide (81,263 reports)

Browse all side effects of Metoclopramide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chest wall abscess:

Chest wall abscess (52 drugs)

Browse all the conditions that are associated with Chest wall abscess:

Chest wall abscess (117 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Metoclopramide) and Metoclopramide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.